Home / Industry Reports / Pharmaceutical Market Research
Sort By: Title Date Price

Central Fill Pharmacy Automation Market By Product & Service Type (Equipment, Software, Services), By Vendor (Equipment Vendors, Sales & Consulting Vendors) - Growth, Future Prospects And Competitive Analysis, 2019 – 2027

The global central fill pharmacy automation market is developing competently, expected to grow at a CAGR of 10.1%. Globally, increasing penetration of pharmacy automation products, advancement in robotics & tabletop devices, and growth in overall software & services for enhanced distribution of pharmaceutical drugs will drive the overall market growth. Rising awareness about central fill automation technology along with the launch of integrated software solutions are key factors driving the growth of the central fill pharmacy automation market on a global scale.

$4325 Read More

Pharmaceutical Intermediates Market By Product (Bulk Drug Intermediates, Chemical Intermediates, Custom Intermediates), By End User (Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organization, Research Laboratories) - Growth, Future Prospects & Competitive Analysis, 2019 – 2027

The pharmaceutical intermediates market is set to reach from US$ 25,965.0 Mn in 2018 to US$ 36,890.6 Mn by 2027 at a compound annual growth rate (CAGR) of 4.0% during the forecast period from 2019 to 2027. Significant rise in drug formulation and research activities and supportive regulatory environment provided by global healthcare agencies will consolidate the pharmaceutical intermediates market during the forecast period.

$4325 Read More

In-Vitro Fertilization Market By Instrument (Disposable Devices, Culture Media and Capital Equipment), By Type (Fresh Donor, Frozen Donor, Fresh Non-Donor and Frozen Non-Donor), By End User (Fertility Clinics and Hospitals) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

The in-vitro fertilization market is set to reach from US$ 15,604.7 Mn in 2017 to US$ 36,854.0 Mn in 2026 projecting outstanding growth at a compounded annual growth rate of 10.1% during the forecast period from 2018 to 2026. Significant rise in couples to have children at later stage of life owing to increasing preference for professional career and technological adoption in IVF treatment will drive the market growth in the forthcoming years.

$4325 Read More

Hematology Diagnostics Market By Restorative Material Product Type (Hematology Instruments, Hematology Consumables), By End-user Segment (Diagnostic Laboratories, Hospitals & Clinics, Academic and Research Institutions) - Growth, Future Prospects, And Competitive Landscape, 2018 - 2026

The global hematology diagnostics market is increasing significantly, was valued at US$ 3,167.2 Mn in 2017 and expected to reach US$ 5,288.3 Mn by 2026. Increasing blood donation procedures, rising incidences of blood disorders along with enhanced diagnostics and hematology testing technologies drives the overall hematology diagnostics market growth. New technological evolution in automated hemotology analyzers would also drive the overall market. Additionally, new standardized automated sample collection, data processing, identification & testing, and ordering of new tests among other processes will further spur revenue growth during the forecast period.

$4325 Read More

Histology and Cytology Market By Type of Examination (Cytology and Histology) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

The histology and cytology market is set to grow from US$ 8,928.1 Mn in 2017 to 27,949.9 Mn by 2026 at a compounded annual growth rate (CAGR) of 13.6% during the forecast period from 2018 to 2026. As per the research citings provided by World Health Organization (WHO) the global burden of cancer is approximately 18.1 million new cases and with 9.6 million deaths in 2018. The major factors responsible for the occurrence of chronic disease are increasing consumption of tobacco, alcohol, junk food, sedentary lifestyle and stress.

$4325 Read More

Generic Oncology Drugs Market By Molecule Type (Small Molecule and Large Molecule) - Growth, Future Prospects & Competitive Analysis, 2018 - 2026

The generic oncology drugs market is set to reach from US$ 17,151.0 Mn in 2017 to US$ 29,222.5 Mn by 2026 representing undeviated growth at a compounded annual growth rate (CAGR) of 6.1% during the forecast period from 2018 to 2026. According to the statistics provided by World Health Organization (WHO) in 2018, 9.6 million people worldwide have been estimated to be dead due to cancer. It is considered as the second leading cause of death, researchers are of the opinion that approximately 30% cancer deaths can be prevented by avoiding risk factors such as alcohol consumption, tobacco smoking, early diagnosis etc. Generic oncology drugs drastically reduce the healthcare cost burden associated with cancer treatment, but still there is ambiguity among healthcare professionals regarding its effectiveness and bioequivalence when compared to branded drugs. Healthcare agencies have made it imperative for pharmaceutical companies to follow ICH and cGMP guidelines while manufacturing generic oncology drugs.

$4325 Read More

Plasma Fractionation Market By Product (Coagulation Factor Concentrates, Immunoglobulin, Albumin, Protease Inhibitors and Others), By Application (Neurology, Immunology, Hematology, Critical Care and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

The plasma fractionation market is set to reach from US$ 18,099.5 Mn in 2017 to US$ 33,386.6 Mn by 2026 at a compound annual growth rate (CAGR) of 7.1% during the forecast period from 2018 to 2026. Plasma fractionation is utilized for achieving large quantities of purified protein from human plasma. Researchers have been focusing diligently in understanding the role and significance of plasma derived proteins in treating chronic ailments and autoimmune diseases. Increasing demand for biologics and increasing healthcare expenditure for drug development activities together drive the plasma fractionation market growth.

$4325 Read More

Endodontics And Orthodontics Market By Type (Endodontics, Orthodontics), By Usage Area (Hospitals, Dental Clinics And Laboratories, Research And Academia) - Growth, Future Prospects And Competitive Analysis, 2018 – 2026

Over half of the global teenage population suffers from dental conditions such as caries, decay or misalignment. The WHO also reports dental treatment among the top five healthcare procedures. Growing awareness about oral health, increasing disposable incomes and augmented preference for dental asthetics, along with the incidence of dental diseases are driving the global endodontics and orthodontics market. Growing number of specialized dentists and orthodontists is also supporting the market growth.

$4325 Read More

Artificial Tendons And Ligaments Market By Application (Knee Injuries, Foot & Ankle Injuries, Shoulder Injuries, Others), By Usage Area (Hospitals, Ambulatory Surgery Centers) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Despite their introduction several years ago, the use of artificial tendons and ligaments have only recently received prominent attention and has opened new treatment options for patients seeking rapid recovery and restoration of normal movements. Artificial ligaments are commonly used in knee, ankle and shoulder treatments where tissue rupture is often observed. These are in high demand in procedure for patellar ligament reconstruction and of anterior cruciate ligament.

$4325 Read More

Veterinary Pain Management Market By Product Type (Drugs, Devices), By Application (Degenerative diseases, Post-surgical orthopedic complexities, Neurologic impairments, Chronic musculoskeletal laxity, Dermatologic diseases, Postchemotherapy gastrointestinal disease) - Growth, Future Prospects and Competitive Analysis 2018-2026

Veterinary pain management market accounted for a market value of US$ 1,078.5 Mn in 2017 and projected to grow at a CAGR of 7.9% during the forecast period from 2018 to 2026. Rising humanization of animals due to developing trend of nuclear family, continuous development in the research & development activities related to the veterinary pain management, and scheduled diagnostics sessions for livestock to maintain the quality of the meat, milk and other products. Improper feeding and unorganized health management of pets & livestock animals leads to obesity and finally leading to joint pain and other disorders. In addition to that, pet and livestock owners are also being counselled & trained by non-government organizations or veterinary doctors to manage health of animals.

$4325 Read More

Pharmaceutical